Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
IGC Pharma, Inc., a clinical stage pharmaceutical company, engages in developing treatments for Alzheimer's disease. The company's lead product is IGC-AD1, which is in a Phase 2B clinical trial as a treatment for agitation in dementia due to Alzheimer's; and TGR-63, IGC-1C, IGC-M3, and LMP in pre-clinical development. The company was formerly known as India Globalization Capital, Inc. and changed its name to IGC Pharma, Inc. in March 2023. The company was incorporated in 2005 and is headquartered in Potomac, Maryland. more
Time Frame | IGC | Sector | S&P500 |
---|---|---|---|
1-Week Return | 4.49% | -2.13% | -0.15% |
1-Month Return | -2.11% | -2.93% | 0.71% |
3-Month Return | 1.09% | 8.56% | 9.92% |
6-Month Return | -13.81% | 13.28% | 12.57% |
1-Year Return | 28.28% | 26.36% | 30.57% |
3-Year Return | -69% | 31.94% | 28.07% |
5-Year Return | -47.61% | 72.24% | 92.45% |
10-Year Return | -49.04% | 150.18% | 197.42% |
Mar '20 | Mar '21 | Mar '22 | Mar '23 | Mar '24 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 4.07M | 898.00K | 397.00K | 911.00K | 1.34M | [{"date":"2020-03-31","value":100,"profit":true},{"date":"2021-03-31","value":22.05,"profit":true},{"date":"2022-03-31","value":9.75,"profit":true},{"date":"2023-03-31","value":22.37,"profit":true},{"date":"2024-03-31","value":33.03,"profit":true}] |
Cost of Revenue | 3.96M | 785.00K | 203.00K | 469.00K | 612.00K | [{"date":"2020-03-31","value":100,"profit":true},{"date":"2021-03-31","value":19.84,"profit":true},{"date":"2022-03-31","value":5.13,"profit":true},{"date":"2023-03-31","value":11.85,"profit":true},{"date":"2024-03-31","value":15.47,"profit":true}] |
Gross Profit | 115.00K | 113.00K | 194.00K | 442.00K | 733.00K | [{"date":"2020-03-31","value":15.69,"profit":true},{"date":"2021-03-31","value":15.42,"profit":true},{"date":"2022-03-31","value":26.47,"profit":true},{"date":"2023-03-31","value":60.3,"profit":true},{"date":"2024-03-31","value":100,"profit":true}] |
Gross Margin | 2.82% | 12.58% | 48.87% | 48.52% | 54.50% | [{"date":"2020-03-31","value":5.18,"profit":true},{"date":"2021-03-31","value":23.09,"profit":true},{"date":"2022-03-31","value":89.67,"profit":true},{"date":"2023-03-31","value":89.03,"profit":true},{"date":"2024-03-31","value":100,"profit":true}] |
Operating Expenses | 6.98M | 8.84M | 15.62M | 12.01M | 10.53M | [{"date":"2020-03-31","value":44.67,"profit":true},{"date":"2021-03-31","value":56.57,"profit":true},{"date":"2022-03-31","value":100,"profit":true},{"date":"2023-03-31","value":76.9,"profit":true},{"date":"2024-03-31","value":67.41,"profit":true}] |
Operating Income | (6.86M) | (8.72M) | (15.43M) | (11.57M) | (9.80M) | [{"date":"2020-03-31","value":-686400000,"profit":false},{"date":"2021-03-31","value":-872400000,"profit":false},{"date":"2022-03-31","value":-1542800000,"profit":false},{"date":"2023-03-31","value":-1157100000,"profit":false},{"date":"2024-03-31","value":-979800000,"profit":false}] |
Total Non-Operating Income/Expense | - | - | - | - | - | [{"date":"2020-03-31","value":"-","profit":true},{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":"-","profit":true},{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true}] |
Pre-Tax Income | (7.32M) | (8.81M) | (15.02M) | (11.51M) | (13.00M) | [{"date":"2020-03-31","value":-731500000,"profit":false},{"date":"2021-03-31","value":-881100000,"profit":false},{"date":"2022-03-31","value":-1501600000,"profit":false},{"date":"2023-03-31","value":-1150600000,"profit":false},{"date":"2024-03-31","value":-1300000000,"profit":false}] |
Income Taxes | 782.00K | 169.00K | (412.00K) | (65.00K) | 3.35M | [{"date":"2020-03-31","value":23.38,"profit":true},{"date":"2021-03-31","value":5.05,"profit":true},{"date":"2022-03-31","value":-12.32,"profit":false},{"date":"2023-03-31","value":-1.94,"profit":false},{"date":"2024-03-31","value":100,"profit":true}] |
Income After Taxes | - | - | - | - | - | [{"date":"2020-03-31","value":"-","profit":true},{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":"-","profit":true},{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true}] |
Income From Continuous Operations | (7.32M) | (8.81M) | (15.02M) | (11.51M) | (13.00M) | [{"date":"2020-03-31","value":-731500000,"profit":false},{"date":"2021-03-31","value":-881100000,"profit":false},{"date":"2022-03-31","value":-1501600000,"profit":false},{"date":"2023-03-31","value":-1150600000,"profit":false},{"date":"2024-03-31","value":-1300000000,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2020-03-31","value":"-","profit":true},{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":"-","profit":true},{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true}] |
Net Income | (8.10M) | (8.98M) | (14.60M) | (11.44M) | (13.00M) | [{"date":"2020-03-31","value":-809700000,"profit":false},{"date":"2021-03-31","value":-898000000,"profit":false},{"date":"2022-03-31","value":-1460400000,"profit":false},{"date":"2023-03-31","value":-1144100000,"profit":false},{"date":"2024-03-31","value":-1300000000,"profit":false}] |
EPS (Diluted) | (0.18) | (0.22) | (0.31) | (0.22) | (0.58) | [{"date":"2020-03-31","value":-18,"profit":false},{"date":"2021-03-31","value":-22,"profit":false},{"date":"2022-03-31","value":-31,"profit":false},{"date":"2023-03-31","value":-21.51,"profit":false},{"date":"2024-03-31","value":-58,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
IGC | |
---|---|
Cash Ratio | 0.55 |
Current Ratio | 1.52 |
Quick Ratio | 0.98 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
IGC | |
---|---|
ROA (LTM) | -47.82% |
ROE (LTM) | -126.20% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
IGC | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.29 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.71 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
IGC | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 27.13 |
P/B | 3.82 |
Price/FCF | NM |
EV/R | 22.78 |
EV/Ebitda | NM |
PEG | NM |
India Globalization Capital Inc (IGC) share price today is $0.391
Yes, Indians can buy shares of India Globalization Capital Inc (IGC) on Vested. To buy India Globalization Capital Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in IGC stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of India Globalization Capital Inc (IGC) via the Vested app. You can start investing in India Globalization Capital Inc (IGC) with a minimum investment of $1.
You can invest in shares of India Globalization Capital Inc (IGC) via Vested in three simple steps:
The 52-week high price of India Globalization Capital Inc (IGC) is $0.91. The 52-week low price of India Globalization Capital Inc (IGC) is $0.25.
The price-to-earnings (P/E) ratio of India Globalization Capital Inc (IGC) is
The price-to-book (P/B) ratio of India Globalization Capital Inc (IGC) is 3.82
The dividend yield of India Globalization Capital Inc (IGC) is 0.00%
The market capitalization of India Globalization Capital Inc (IGC) is $28.81M
The stock symbol (or ticker) of India Globalization Capital Inc is IGC